Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2026 17:33 ET | Source: Tango Therapeutics Sub, Inc BOSTON,…
Revive Environmental Announces CEO Transition
COLUMBUS, Ohio, March 06, 2026 (GLOBE NEWSWIRE) -- Revive Environmental Technology, LLC,…
Bybit Announces Departure of Co-CEO Helen Liu as She Embarks on Entrepreneurial Journey
DUBAI, UAE, March 7, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
AIM ImmunoTech Announces Closing of its Rights Offering
OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE…
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
Study is Real-World Evaluation of the Clinical Utility of Sodium Thiosulfate Injection (PEDMARK®)…
The Ferrero Group announces new governance and leadership roles, reporting into Giovanni Ferrero, President of Ferrero International S.A.
Alessandro Nervegna will be appointed as new Chief Executive Officer of Ferrero…
Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing
Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”),…
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq:…
3iQ Announces Successful Closing of Previously Announced Transaction with Coincheck Group N.V.
TORONTO, March 2, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer…
Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit
LEHI, Utah, March 2, 2026 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
